Frank M. Sands serves as Executive at Acumen Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Frank M. Sands has executed 4 insider transactions totaling $9.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 21, 2025 involved purchasing 2,068,965 shares valued at $3.0M.
Frank M. Sands currently holds 13,018,965 shares of Acumen Pharmaceuticals, Inc. (ABOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank M. Sands has been a net buyer of ABOS stock. They have purchased $9.7M and sold $0 worth of shares.
Frank M. Sands's most recent insider trade was on Nov 21, 2025, when they purchased 2,068,965 shares at $1.45 per share.
Get notified when new Form 4 filings are submitted
| $14.88 |
| Discretionary |
| Jul 6, 2021 | ABOS | $0 | Conversion | 1,124,729 | $N/A | Discretionary |
| Jul 6, 2021 | ABOS | $0 | Conversion | 1,842,346 | $N/A | Discretionary |